BACKGROUND: Circulating concentrations of leptin normalized to total adipose tissue mass are significantly greater in females than in males. Rates of leptin expression (per gram of adipose tissue) are significantly greater in subcutaneous (SAT) than visceral (VAT) adipose tissue and the relative amount of fat stored as SAT vs VAT is significantly greater in pre-menopausal females than in males. Gender-related differences in the relative amounts of SAT and VAT may account for the greater circulating leptin concentration relative to fat-mass in females than males. METHODS: We examined body composition and anatomic fat distribution by dual energy X-ray-absorptiometry (DEXA) and magnetic resonance imaging (MRI), and post-absorptive circulating concentrations of leptin and insulin in 58 subjects (26 females, 32 males). Stepwise multiple linear regression analyses, treating gender as a dichotomous variable, were performed to determine inter-relationships among leptin concentrations and insulin concentrations, VAT and SAT. RESULTS: Body composition by DEXA and MRI were highly correlated (r 2 ¼ 0.97, P < 0.0001). There were significant gender effects on leptin=total fat mass (males, 0.17 AE 0.01 ng=ml=kg; females, 0.49 AE 0.05 ng=ml=kg; P < 0.0001) and relative amounts of fat in SAT and VAT depots (ratio of SAT=VAT; males, 12.3 AE 1.5; females, 32.9 AE 3.2; P < 0.0001). Circulating leptin concentration was significantly correlated with insulin concentration (P ¼ 0.001), SAT (P < 0.0001) and gender (P ¼ 0.033). Circulating concentrations of insulin were significantly correlated with VAT, but not SAT, in males and with SAT, but not VAT, in females. CONCLUSIONS: The sexual dimorphism in the relationship between leptin and adipose tissue mass cannot be explained by differences in the relative amounts of VAT and SAT. Thus, the sexual dimorphism in plasma leptin concentration appears to reflect, at least in part, effects of circulating concentrations of gonadal steroids (especially androgens) and=or primary genetic differences that are independent of amounts of VAT or SAT.
Introduction
Circulating concentrations of leptin vary directly with adipose tissue mass, and may constitute an afferent limb of a system regulating body fatness. 1 -3 Circulating concentrations of leptin, normalized to total fat mass, are 2 -3 fold higher in pre-menopausal females than in males. 2,4 -7 It is not clear whether this sexual dimorphism is attributable to gender-based differences in circulating concentrations of gonadal steroids, relative amounts of body fat in different anatomic depots, or primary (non-gonadal) genetic differences.
The rate of expression of leptin mRNA is greater in subcutaneous (SAT) than in visceral adipose tissue (VAT) depots. 8, 9 In comparison to males, adult females have a significantly greater proportion of their fat mass in SAT (vs VAT) depots. 10, 11 Nagy et al 12 reported that, in prepubertal children, gender was not a significant determinant of circulating leptin concentrations when adjusted for genderrelated differences in body composition and adipose tissue distribution in visceral and subcutaneous depots. They suggested that higher circulating concentrations of leptin in females were due to their proportionately greater volume of SAT compared to males. Other studies have found that circulating concentrations of leptin, corrected for body composition, are significantly decreased in males compared to females at later stages of puberty. 13 However, the relatively small amount of VAT, relative to SAT in most humans of either sex, 10, 11 makes it unlikely that differential rates of leptin mRNA expression in adipose tissue from these depots would be sufficient to account for the striking sexual dimorphism in circulating concentrations of leptin. Using magnetic resonance imaging (MRI) and dual energy X-ray absorptiometry (DEXA), we measured the volume of adipose tissue in VAT and SAT depots. These measures were related by stepwise linear regression to postabsorptive circulating concentrations of insulin and leptin in males and females to determine whether the effects of gender (ie individuals differing in circulating concentrations of androgens, estrogens and possible non-gonadal genetic sex differences) on circulating concentrations of leptin were due to differences in amounts of adipose tissue in subcutaneous and visceral depots.
Methodology

Subjects
We studied a total of 58 subjects (26 pre-menopausal females, 32 males). All subjects were in good health. Written informed consent was obtained from all subjects. Subject characteristics are presented in Table 1 .
Protocol
All subjects were studied in the post-absorptive state. Body composition was determined by DEXA 14 and by MRI. 15, 16 Whole-body MRI scans were performed using a 1.5 T scanner (model no. 6X Horizon, General Electric Corporation, Milwaukee, WI), axial T 1 weighted spin echo sequence, 10 mm slice thickness, and 40 mm interslice gap. 17 Forty to fifty cross-sectional images were prepared on each subject. Adipose tissue and skeletal muscle volumes within each slice were then calculated by a single trained observer using VECT image analysis software (Martel Inc., Montreal, Canada). Total body adipose tissue, SAT, VAT and skeletal muscle volumes were calculated from the combined cross-sectional tissue areas as reported by Ross. 17 The mass of each compartment was calculated as the product of volume and density (0.92 g=cm 3 for adipose tissue and 1.04 g=cm 3 for skeletal muscle). A single trained observer read all of the MRI scans. Total body mass was measured with a whole body DEXA scanner (Lunar Corp. Madison, WI, version 3.6 software). This software package allows resolution of whole body fat and fat-free body mass components.
Prior to body composition assessment, plasma was obtained from each subject for determination of circulating concentrations of insulin and leptin.
Assays
Circulating concentrations of insulin were measured by radioimmunoassay. 18 Leptin was measured in serum samples using a commercial radioimmunoassay (Human Leptin RIA Kit, Linco Research, St Louis, MO). Anti-leptin antiserum used in this assay was raised in rabbits against purified recombinant human leptin. 1 The antiserum had no crossreactivity with human insulin, C-peptide, glucagon, IGF-1, somatostatin or pancreatic polypeptide. Recombinant human leptin and 125 I-labeled human leptin were used as standard and tracer, respectively. Standards and samples were incubated in PBS, pH 7.4, containing 0.1% Triton X-100 and 1.0% bovine serum albumin for 21 h at 4 C. The bound fraction was precipitated with polyethylene glycol and anti-rabbit antiserum, and the pellet counted. The range of the standard curve was 0.5 -100 ng=ml, and leptin levels above 100 ng=ml were reassayed upon dilution. The mean inter-and intra-assay coefficients of variation (CV) for the leptin RIA were 4.5 and 4.9 ng=ml, respectively. 19 
Statistical analyses
Multiple forward stepwise linear regression analyses (F to enter ¼ 1.00, F to remove ¼ 0.00) with ridge regression (l ¼ 0.10) were used to determine effects of circulating concentrations of insulin, VAT volume, SAT volume, fat-free mass and gender on circulating concentrations of leptin. Similar analyses were performed on the data using total fat volume instead of VAT and SAT volumes to determine whether the regressions were significantly improved by accounting for fat distribution. Stepwise regression analyses with ridge regressions were used to control for the colinearity of variables, for example fat mass and insulin, fat-free mass and gender. This type of forward stepwise analysis eliminates Sexual dimorphism in circulating leptin concentrations M Rosenbaum et al variables from the regression equation which, once adjusted for the effects of other independent variables, do not increase the r-value for the entire regression. These variables, so eliminated, are not included in the final regression equation and their partial correlation coefficients and P-values are not presented (Tables 2 and 3 ). Simple linear regression analyses were used to examine the correlation of whole body adipose tissue mass measured by DEXA, and whole body adipose tissue volume measured by MRI. All analyses were performed on a Dell Dimension XPS M200 PC using the Statistica (Statsoft, Tulsa, OK) statistical analysis package, version 5.1. 20 Statistical significance was prospectively defined as P a < 0.05.
Results
Total adipose tissue mass (fat) determined by DEXA and total adipose tissue volume (sum of VAT and SAT) determined by MRI were highly correlated (r 2 ¼ 0.97, P < 0.0001, Figure 1 ). There was a clear sexual dimorphism in the ratio of leptin=total fat mass (0.17 AE 0.01 ng=ml=kg in males vs 0.51 AE 0.05 ng=ml=kg in females, P < 0.0001) and SAT=VAT volumes (12.3 AE 8.5 in males vs 32.6 AE 15.9 in females, P < 0.0001) (Table 1, Figure 2 ). Of note, there was no significant gender effect on SAT mass or total adipose tissue mass. The significant gender-effect on the SAT=VAT volume was conveyed by the significantly higher VAT volume in males rather than a higher SAT volume in females. The lack of significant gender difference in total adipose tissue mass, despite the difference in VAT volume reflects the relatively small percentage of total adipose tissue volume accounted for by VAT (approximately 5 -10%), the large variance in the adipose tissue volume of the population studied, and the number of subjects studied.
The regression equations relating circulating leptin concentrations to fat mass have non-zero intercepts, especially in females: males -leptin ¼ 0.20 (fat mass (kg)) 70.8, r 2 ¼ 0.49, P < 0.0001; females -leptin ¼ 0.85 (fat volume (l)) 76.4, r 2 ¼ 0.49, P < 0.0001. To avoid the possible confounding effects on leptin=fat mass ratios of the non-zero intercepts of the leptin vs fat mass regressions, the predicted concentrations of leptin in females were calculated using the regression equation describing plasma leptin in terms of total fat mass in females (leptin ¼ 0.88 (fat mass (kg)) 75.4). The residual plasma leptin concentration calculated for males using the female regression equation was 75.7 AE 0.8 ng=ml, P < 0.0001 compared to zero.
Insulin increases the expression of leptin in adipocytes in vitro and in vivo. 21, 22 In multiple forward stepwise regression analyses, circulating concentrations of insulin were significantly related to VAT, but not SAT, in males, and to SAT, but not VAT, in females. If insulin was not included as a covariate, then circulating concentrations of leptin were significantly correlated with both SAT and VAT in males, but only with SAT in females. These data suggest that whatever effect the small VAT depot has on circulating leptin concentrations in males is conveyed via the effects of VAT on circulating insulin concentrations (Tables 2 and 3) . Table 2 Equations predicting leptin concentrations from VAT, SAT, FFM and circulating concentrations of insulin Sexual dimorphism in circulating leptin concentrations M Rosenbaum et al
In forward stepwise regression analyses, circulating leptin concentration was significantly correlated with insulin concentration (P ¼ 0.0071), SAT volume (P < 0.0001), and gender (P ¼ 0.033), but not with age, FFM or VAT volume. These independent variables accounted for 63% of the variation in plasma concentrations of leptin. The inclusion of VAT volume or the SAT=VAT volume ratio in the regression analysis did not account for additional variation in circulating leptin (Table 4) . Similarly if leptin=fat mass were the dependent variable and gender, SAT=VAT ratio, and insulin were independent variables, only insulin (P ¼ 0.005) and gender (P < 0.0001) were significant covariates of circulating Sexual dimorphism in circulating leptin concentrations M Rosenbaum et al concentrations of leptin per unit of fat mass. These independent variables accounted for 53% of the variation in leptin=fat mass. When all covariates (SAT, VAT, FFM, insulin) were analyzed by ANCOVA with leptin as the dependent variable and gender as the independent factor a significant gender effect remained. Adjusted cell means for leptin were 7.9 ng=ml for females and 5.4 ng=ml for males (P ¼ 0.036), indicating that a significant sexual dimorphism in circulating leptin concentrations (females > males) remains even when data are corrected for body composition, body fat distribution and circulating concentrations of insulin. Because of possible effects of menopause on the SAT=VAT ratio, we also measured leptin concentrations and adipose tissue distribution in nine post-menopausal females (mean AE s.d. age ¼ 59 AE 6.1 y, BMI 26.6 AE 4.5 kg=m 2 ). There was a significant effect of menopause only on the SAT=VAT volume ratio (15.1 AE 17.1 in post-menopausal females vs 32.6 AE 15.9 in pre-menopausal females, P < 0.001) and on adipose tissue mass (24.9 AE 8.6 kg in post-menopausal females vs 17.0 AE 5.3 kg in pre-menopausal females, P < 0.001) and volume (26.6 AE 9.2 l in post-menopausal females vs 17.8 AE 4.7 l in post-menopausal females, P < 0.001). With the caveat that we studied a relatively small number of post-menopausal females, if differential rates of leptin production by VAT and SAT were significant causes of the sexual dimorphism in circulating leptin concentrations then the greater proportion of VAT in postmenopausal females should result in a significantly lower concentration of leptin normalized to fat mass. However, despite the greater proportion of VAT in post-menopausal females, we detected no effect of menopause on the ratio of leptin=fat mass (0.66 AE 0.18 ng=ml=kg in post-menopausal females vs 0.49 AE 0.25 ng=ml=kg in pre-menopausal females), but the ratio of leptin=fat mass in post-menopausal females was still significantly greater than in males (0.17 AE 0.01 ng=ml=kg) (Figure 2 ).
Discussion
Possible explanations for the striking sexual dimorphism in circulating leptin concentrations include more subcutaneous relative to visceral fat in women, effects of gonadal steroids on leptin production and=or clearance, and primary effects of genes located on the X or Y chromosome but independent of gonadal steroids. The major finding of this study is that this dimorphism is not accounted for by gender-based differences in the amount of fat in subcutaneous and visceral depots or in circulating insulin concentrations. This conclusion is concordant with a report by Weigle et al 23 that plasma leptin concentrations did not differ significantly between individuals in the highest and lowest quartile for intraabdominal fat mass measured by computerized tomography.
Numerous studies support the inference that some portion of the adult sexual dimorphism in plasma leptin concentration is hormonally mediated. Ovariectomy in adult rats causes a significantly decline in circulating leptin concentrations that is reversed by estradiol supplementation. 24 Circulating plasma leptin concentrations, normalized to body mass index (BMI) (a surrogate indicator of fat mass), are significantly increased in hypogonadal compared to eugonadal men, and leptin concentrations are lowered in hypogonadal men following administration of testosterone. 25 Administration of estradiol and cyprotereone acetate (an androgen receptor antagonist) to transsexual males increases circulating plasma leptin concentration (160 -180%) while administration of testosterone to transsexual females increased body weight and decreases circulating leptin concentration (750 -60%). In these studies, hormonal sex, but not genetic sex, was a significant determinant of plasma leptin concentration. Incubation of adipose tissue with testosterone decreases leptin mRNA expression, and circulating testosterone concentration accounts for a significant fraction of the variability in circulating concentrations of leptin among obese boys at all stages of puberty Table 4 Multiple forward stepwise linear regression analysis with ridge regression of variables affecting circulating concentration of leptin Dependent variable
All subjects, adjusted r 2 ¼ 0.63; P < 0.0001 Tolerance limits were set as F to enter ¼ 1.00, F to remove ¼ 0. P-values for intercepts are probability that intercept is not equal to zero. Variables that do not meet the tolerance limits, ie do not explain any addition portion of the variance in circulating leptin concentrations, are automatically excluded from the regression equation.
Sexual dimorphism in circulating leptin concentrations M Rosenbaum et al (r ¼70.35, P < 0.0001), 13, 26 and among adult men (r ¼70.32, P < 0.01). 27 Horlick et al 13 reported that there was a marked suppression of circulating leptin concentrations corrected for body composition in males at Tanner stages IV and V and a smaller increase in circulating concentrations of leptin corrected for body composition in females at these later Tanner stages. They also noted a significant negative correlation of the ratio of leptin to fat mass and circulating testosterone concentration in males (r ¼ 7 0.46, P ¼ 0.0004), but no significant correlation between leptin=fat mass and estradiol in females. They concluded that circulating androgens were the major cause the sexual dimorphism in circulating leptin concentrations. Some studies have reported that circulating concentrations of leptin are lower in post-menopausal women than in premenopausal women, 2 however, the sexual dimorphism in circulating leptin concentrations persists even when males are compared to post-menopausal females, 2 as observed in this study. The peristence of this sexual dimorphism in a population including both pre-and post-menopausal females only serves to strengthen the inference that adipose tissue distribution is not sufficient to account for the higher circulating concentrations of leptin in females and that the primary determinant of this sexual dimorphism is circulating concentrations of androgens, rather than estrogens, which decline post-menopause.
The relatively small VAT depots present in both males and females do not account for a significant portion of circulating leptin in a forward stepwise linear regression model that includes VAT, SAT and insulin. If insulin is not included, VAT becomes a significant predictor of circulating leptin concentration in males, suggesting that the correlation between VAT and circulating concentration of leptin is mediated by effects of VAT on circulating insulin concentration. In contrast, the much larger SAT depot accounts for approximately 40% of the variance in circulating leptin concentrations in females (P < 0.0001) and 45% of the variance in males (P < 0.0001). Circulating concentrations of insulin do not account for a significant percentage of the variance in circulating leptin concentrations in females, but do account for an additional 31% of the variance in males (P < 0.001).
Rates of leptin production in SAT are 2 -3 times greater than in VAT 8, 9, 28 and, as noted in the present study and others, 29 -31 increased VAT is associated with increased circulating insulin. The positive correlation of circulating insulin concentration with VAT may be sufficient to mask any potential effects of VAT related to its intrinsic leptin production rate. 29 -31 However, Doucet et al recently reported that circulating concentrations of insulin are associated with an increase in circulating leptin concentrations which is independent of fat mass. 40 Leptin secretion is pulsatile, and pulse frequencies and amplitudes were not measured in this study. However, ultraradian periodicities in leptin secretion detected by Fourier analysis are similar in adult men and women, 32 and the major gender-related differences in leptin secretion in adults appear to be due to pulse amplitude rather than frequency. 33 Most studies of the sexual dimorphisms in circulating leptin concentrations have focussed on postabsorptive concentrations. However, it is possible that there are effects of adipose tissue distribution on pulse frequency or amplitude. Alterations in either of these parameters, as well as possible changes in leptin-clearance rates, ie gender-effects similar to those seen in the metabolism of growth hormone, 34 could also play a role in observed sexual dimorphism in circulating leptin concentrations.
In summary, there is a gender-based difference in the relationship between leptin and adipose tissue mass in adults that cannot be fully accounted for by differences in either total fat mass, the relative amounts of adipose tissue in visceral and subcutaneous depots, or concentrations of circulating insulin. This sexual dimorphism is probably mediated largely by gonadal steroids, but may also reflect primary genetic effects on leptin production, release and=or clearance. Leptin concentrations in cord blood are significantly lower in male compared to female neonates though circulating concentrations of estradiol and testosterone were not significantly different between these groups. 35 The observed sexual dimorphism of leptin concentrations in cord blood may reflect reflecting primary genetic effects or the effects of the prenatal sexual dimorphisms in androgen (male > female) concentrations which begin early in gestation (at the time of Leydig cell proliferation) and persist until the perinatal gonadal surge. 36, 37 If there is a primary genetic effect on circulating concentrations of leptin which is independent of gonadal steroids, then that effect should still be evident in prepubertal children. Medical literature, to our knowledge, remains divided on this issue. Some studies of prepubertal children have reported that females have higher concentrations of circulating leptin than males, 13 ,38 while others have not reported a significant gender-effect prior to puberty. 39 Examination of individuals with poly-X and=or poly-Y syndromes, as well as individuals with Turner's syndrome, testicular feminization, and other syndromes in which hormonal and genetic sex are discordant should shed further light on these issues.
